Blog · manufacturing insights
COA vs Full QA Packet: What B2B Peptide Buyers Should Request
· Peptisova
Many peptide RFQs stall on a deceptively simple question: “Do you have a COA?” Yes/no answers hide a second question that actually drives delays—what else belongs in the release file for this purchase?
This guide helps B2B buyers distinguish a lot Certificate of Analysis (COA) from a full QA / documentation packet. It is written for cosmetic brands, distributors, lab/industrial procurement, and OEM programs working with a manufacturing partner—not for consumer retail or clinic kit shopping.
Primary diligence surfaces on Peptisova: COA Vault and Quality & documentation. For what a COA does and does not prove, keep What a Peptide COA Actually Proves open beside this page.
Definitions buyers can share with stakeholders
| Term | Working definition |
|---|---|
| Lot COA | Lot release record: identity/tests/results for a named batch against an agreed specification |
| Full QA packet | Broader document set your program needs to approve, import, label, or private-label a shipment—not a single universal PDF |
| Marketing / typical sheet | Non-lot promotional summary; useful for browsing, not for release |
There is no single global “full QA packet” template that every peptide PO requires. Destination, format (vial vs powder), OEM branding, and RUO vs cosmetic raw-material context change the list. The job is to write the list, not to collect random certificates.
Side-by-side comparison
| Need | Usually covered by lot COA? | Often needs extra packet items |
|---|---|---|
| Lot ID + HPLC purity (method-bound) | Yes | Chromatogram attachment; method summary |
| MS confirmation when spec requires | Sometimes on COA | Explicit MS report / identity note |
| Packing list / ship lot match | No (separate) | Packing list with lot IDs |
| Private-label artwork + insert languages | No | OEM artwork freeze + release pack |
| Destination / export paperwork | No | Scoped per RFQ / destination |
| Proof the seller manufactured the lot | No | Supplier verification process |
| Clinical efficacy / dosing safety | Never | Wrong document class entirely |
When a lot COA is enough (and when it is not)
Often enough for
- Catalog Track A trial orders where your internal QA accepts lot COA + packing list
- Reorders of a fixed specification when batch hygiene is already defined (batch numbers guide)
- Early technical diligence using sample vault files as format examples only
Not enough alone for
- First OEM private-label kit programs (OEM packaging steps; OEM hub)
- Buyers who require MS identity, specific related-substance limits, or destination certificates
- Stakeholders who confuse “SAMPLE” vault PDFs with production lot files
- Any request that tries to stretch a COA into therapeutic or consumer-claim permission (Compliance)
Building a practical packet checklist
Use this as a starting checklist—delete what your program does not need; do not invent certificates you do not use:
- Lot COA with method context (COA Vault)
- HPLC chromatogram for the release lot (how to read chromatograms)
- MS confirmation if your specification requires it (HPLC/MS checklist)
- Packing list with lot IDs matching COA
- OEM set (languages, carton/insert, artwork freeze) when branding
- Destination docs named explicitly in the RFQ
- Claim boundary note so marketing does not over-read analytical files (GMP-ready language vs unverified claims)
Peptisova will not claim a GMP certificate you have not issued, and we will not encourage “GMP-ready” marketing language as a substitute for certificates you do not hold.
Dual-track commerce and documentation
| Track | Typical docs expectation |
|---|---|
| Track A — catalog MOQ checkout | Lot COA + packing list; vault samples for diligence UX |
| Track B — custom / complex OEM / bulk API | Spec + docs list scoped on Quote Cart; no fake instant price for complex packs |
Browse priced catalog SKUs on /products. Scope OEM on /oem-private-label. Bulk powder paths: /bulk-peptide-api.
RFQ stub
> Documentation RFQ: SKU or sequence ___; quantity/format ___; lot COA with HPLC [yes]; chromatogram [yes/no]; MS [required/not]; packing list [yes]; OEM artwork/languages ___; destination docs ___; claim framing: cosmetic raw material / RUO industrial (circle one).
Submit via Quote Cart. For ownership diligence while shortlisting, use How to verify a supplier.
Related reading
- What a Peptide COA Actually Proves
- HPLC and MS checklist
- How to read a peptide HPLC chromatogram
- GMP-ready language vs unverified claims
- COA Vault · Quality · Quote Cart
Peptisova is a B2B peptide manufacturing and private-label partner. Lot documentation supports industrial, research-use, and cosmetic raw-material supply. We do not provide consumer dosing guidance or Melanotan / weight-loss retail programs.
FAQ
Is the COA Vault the same as my production release pack?
No. The vault shows sample/demo lots for diligence. Commercial shipments need matching production lot docs.
Can one PDF replace OEM packaging control?
No. Artwork, carton, and insert scope are OEM program items—not COA fields.
Do you provide dosing or clinic dispense packets?
No. Peptisova declines consumer dosing, Melanotan/performance merchandising, and clinic-dispense framing (Compliance; Fact Sheet).
Where should I send stakeholders who only want “the COA”?
Send them this page plus What a COA proves, then collect a written packet list before PO.
Next step
Continue on the primary resource for this topic, then use secondary links below for docs and RFQ.